| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/06/2011 | US8012463 Coordination complex of diaminocyclohexaneplatinum(II) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same |
| 09/06/2011 | US8012460 Mixture of hydroxyethyl cellulose, xanthan gum and carbopol" |
| 09/06/2011 | US8012382 Molded waveguides |
| 09/06/2011 | CA2431977C Synthesis of high molecular weight non-peptidic polymer derivatives |
| 09/06/2011 | CA2402774C Microsphere hydrogel biomedical articles |
| 09/06/2011 | CA2396148C Improved pediatric formula and methods for providing nutrition and improving tolerance |
| 09/06/2011 | CA2364027C Iodine preparation composition |
| 09/06/2011 | CA2363123C Solid oral dosage form containing an enhancer |
| 09/05/2011 | CA2733677A1 Partial esters of a polyglycerol with at least one carboxylic acid and one polyfunctional carboxylic acid, their preparation and use |
| 09/02/2011 | WO2010097344A1 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
| 09/02/2011 | CA2784516A1 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
| 09/01/2011 | WO2011106702A2 Sustained delivery of therapeutic agents to an eye compartment |
| 09/01/2011 | WO2011106595A1 Adhesive complex coacervates produced from electrostatically associated block copolymers and methods for making and using the same |
| 09/01/2011 | WO2011106492A1 Oral care compositions |
| 09/01/2011 | WO2011106481A1 Dna dendrimers as thermal ablation devices |
| 09/01/2011 | WO2011106297A2 Compositions and methods for the diagnosis and treatment of tumor |
| 09/01/2011 | WO2011105963A1 Photosensitizer-containing composition |
| 09/01/2011 | WO2011105835A2 Method and apparatus for preparing novel liposome |
| 09/01/2011 | WO2011105539A1 Coated solid preparation |
| 09/01/2011 | WO2011105534A1 Hard capsule and method for producing same |
| 09/01/2011 | WO2011105520A1 Composite body for antigen or drug delivery |
| 09/01/2011 | WO2011105492A1 Transdermal preparation |
| 09/01/2011 | WO2011105486A1 Adhesive patch |
| 09/01/2011 | WO2011105402A1 Short-chain cationic polyamino acid and use thereof |
| 09/01/2011 | WO2011105257A1 Additive for erythrocyte-rich solution, and container for medical purposes |
| 09/01/2011 | WO2011104631A1 Sn-38 compositions |
| 09/01/2011 | WO2011104625A1 Cyclopolysaccharide compositions |
| 09/01/2011 | WO2011104565A1 Camelid antibodies for use in compositions and methods for the treatment of cancer |
| 09/01/2011 | WO2011104562A1 Fungal nail treatment composition |
| 09/01/2011 | WO2011104557A1 Protein formulations |
| 09/01/2011 | WO2011104497A1 Method for the preparation of a novel nanoparticle conjugate |
| 09/01/2011 | WO2011104234A2 Multiplication of the efficacy of anti-infectious agents by a composition further comprising a dispersing agent together with a metal activating agent |
| 09/01/2011 | WO2011104208A1 Method for preparing a composition including a compound containing vanillin and ethylvanillin, composition thus obtained and use thereof |
| 09/01/2011 | WO2011104169A1 Compositions for targeted delivery of sirna |
| 09/01/2011 | WO2011104134A1 Saccharide derivatives |
| 09/01/2011 | WO2011103961A1 Cross-linking agents for hydrogels that contain cleavable peptides and short-chain polymers |
| 09/01/2011 | WO2011103920A2 Pharmaceutical or neutraceutical formulation |
| 09/01/2011 | WO2011103718A1 Controlled (sustained) release preparation containing quetiapine and preparation method and use thereof |
| 09/01/2011 | WO2011063952A8 Formulations of bisphosphonates and vitamin d suitable for intermittent intramuscular and subcutaneous administration |
| 09/01/2011 | WO2011059931A9 Nanosuspension of a poorly soluble drug made by microfluidization process |
| 09/01/2011 | WO2011034396A3 Solid dispersion comprising a fibrate drug, and method for preparing the solid dispersion |
| 09/01/2011 | WO2011031116A3 Pad for herbal medicine in which release of medicinal ingredient can be controlled, and manufacturing method thereof |
| 09/01/2011 | WO2010119367A3 A medicinal cream made using hydrocortisone acetate and a process to make the same |
| 09/01/2011 | WO2010114982A3 Lyophilization cakes of proteasome inhibitors |
| 09/01/2011 | WO2010030366A3 Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method |
| 09/01/2011 | US20110213470 Methods for using a three-dimensional stromal tissue to promote angiogenesis |
| 09/01/2011 | US20110213014 Compositions and methods for topical delivery of oligonucleotides |
| 09/01/2011 | US20110213002 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 09/01/2011 | US20110212912 Optimised formulation of tobramycin for aerosolization |
| 09/01/2011 | US20110212884 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 09/01/2011 | US20110212182 Masked taste pharmaceutical granules/granulates |
| 09/01/2011 | US20110212163 Magnetic heating for drug delivery and other applications |
| 09/01/2011 | US20110212152 Modified anti-microbial surfaces, devices and methods |
| 09/01/2011 | US20110212141 Injectable depot formulation comprising crystals of iloperidone |
| 09/01/2011 | US20110212048 Polymalic acid-based multifunctional drug delivery system |
| 09/01/2011 | US20110212028 Chemically modified cell-penetrating peptides for improved delivery of gene modulating compounds |
| 09/01/2011 | US20110212027 Radiative heating for drug delivery and other applications |
| 09/01/2011 | DE10320604B4 Partikel umfassend ein Biopolymer, das unter Einwirkung von elektromagnetischen Wellen, ausgestrahlt durch Sonneneinstrahlung, abbaubar ist Particles comprising a biopolymer that is under the influence of electromagnetic waves emitted by the sun, degradable |
| 09/01/2011 | CA2791278A1 Sustained delivery of therapeutic agents to an eye compartment |
| 09/01/2011 | CA2790918A1 Pharmaceutical or neutraceutical formulation |
| 09/01/2011 | CA2790895A1 Protein formulations |
| 09/01/2011 | CA2790577A1 Psma binding ligand-linker conjugates and methods for using |
| 09/01/2011 | CA2789789A1 Dna dendrimers as thermal ablation devices |
| 09/01/2011 | CA2789320A1 Method and apparatus for preparing liposomes using supercritical fluid |
| 09/01/2011 | CA2788998A1 Adhesive complex coacervates produced from electrostatically associated block copolymers and methods for making and using the same |
| 09/01/2011 | CA2788600A1 Compositions for targeted delivery of sirna |
| 09/01/2011 | CA2788423A1 Oral care compositions |
| 09/01/2011 | CA2787657A1 Compositions and methods for the diagnosis and treatment of tumor |
| 09/01/2011 | CA2785694A1 Coated solid montelukast preparation |
| 08/31/2011 | EP2361988A1 Molecular marker for cancer stem cell |
| 08/31/2011 | EP2361978A1 Polypeptides capable of eliciting an immune reaction against cancer |
| 08/31/2011 | EP2361930A2 Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases |
| 08/31/2011 | EP2361918A1 Novel prostaglandin e1 derivative, and nanoparticle having same encapsulated therein |
| 08/31/2011 | EP2361637A1 Formulation of human antibodies for treating TNF-alpha associated disorders |
| 08/31/2011 | EP2361635A2 Anti IgE vaccines |
| 08/31/2011 | EP2361630A1 Implantable drug delivery device comprising particles and an osmotic pump |
| 08/31/2011 | EP2361629A1 Prevention and treatment of synucleinopathic disease |
| 08/31/2011 | EP2361614A2 Fast dissolving oral tablets and method for production thereof |
| 08/31/2011 | EP2361613A1 Stabilized compositions of proteins having a free thiol moiety |
| 08/31/2011 | EP2361612A2 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
| 08/31/2011 | EP2361611A2 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
| 08/31/2011 | EP2361610A1 Ophthalmic compositions containing a synergistic combination of two polymers |
| 08/31/2011 | EP2361609A1 Sustained release small molecule drug formulation |
| 08/31/2011 | EP2361591A2 Methods and compositions for enhancing vascular access |
| 08/31/2011 | EP2361315A1 Cxcl4l1 as a biomarker of pancreatic cancer |
| 08/31/2011 | EP2361260A1 Novel transporter constructs and transporter cargo conjugate molecules |
| 08/31/2011 | EP2361259A1 Efficient transport into white blood cells |
| 08/31/2011 | EP2361098A2 Compositions and methods for delivering a substance to a biological target |
| 08/31/2011 | EP2361091A1 Bile acids and biguanides as protease inhibitors for preserving the integrity of peptides in the gut |
| 08/31/2011 | EP2361084A2 Electrostatically charged multi-acting nasal application, product, and method |
| 08/31/2011 | EP2217208B1 Nucleic acid complex and nucleic acid delivery composition |
| 08/31/2011 | EP2193204B1 Compositions comprising lipophosphoramides and their uses in gene therapy |
| 08/31/2011 | EP2022850B1 Flavin adenine dinucleotide-binding glucose dehydrogenase |
| 08/31/2011 | EP1682582B1 Method for the mass production of immunoglobulin constant region |
| 08/31/2011 | EP1660037B1 Aripiprazole injectable suspension |
| 08/31/2011 | EP1634589B9 Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 08/31/2011 | EP1523325B1 Methods and compositions for treating polycystic ovary syndrome |
| 08/31/2011 | EP1467712B2 Method of producing a bilayer pharmaceutical tablet comprising telmisartan and hydrochlorothiazide |
| 08/31/2011 | EP1443938B1 Dosage unit comprising a prostaglandin analog for treating constipation |
| 08/31/2011 | EP1402015B1 A soluble complex comprising a retroviral surface glycoprotein and fkpa or slyd |